Hexa Tradex Board Re-appoints Independent Director Dr. Vinita Jha and Statutory Auditors M/s Lodha & Co. at May 11, 2026 Meeting
Hexa Tradex Limited's Board of Directors, at their May 11, 2026 meeting, approved the re-appointment of Dr. Vinita Jha as Independent Director for a second term of 5 consecutive years effective June 25, 2026, and the re-appointment of M/s Lodha & Co., Chartered Accountants, as Statutory Auditors for a second term of 5 consecutive years from the 15th AGM till the 20th AGM (on or before September 30, 2031). Both appointments are subject to shareholder approval at the ensuing Annual General Meeting. The disclosures were made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

*this image is generated using AI for illustrative purposes only.
Hexa Tradex Limited's Board of Directors, at their meeting held on May 11, 2026, approved two significant governance decisions: the re-appointment of Dr. Vinita Jha as an Independent Director and the re-appointment of M/s Lodha & Co., Chartered Accountants, as the company's Statutory Auditors. The board meeting commenced at 05:30 P.M. and concluded at 06:40 P.M. Both decisions are subject to shareholder approval at the ensuing Annual General Meeting. The disclosures were made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Key Governance Appointments
The following table summarises the two appointments approved by the Board:
| Parameter: | Dr. Vinita Jha | M/s Lodha & Co. |
|---|---|---|
| Role: | Independent Director | Statutory Auditors |
| Nature of Change: | Re-appointment | Re-appointment |
| Term: | 2nd term of 5 consecutive years | 2nd term of 5 consecutive years |
| Effective Date: | June 25, 2026 | Date of AGM (June 24, 2026) |
| Tenure End: | — | Conclusion of 20th AGM (on or before September 30, 2031) |
| Subject To: | Shareholder approval at ensuing AGM | Shareholder approval at ensuing AGM |
| Debarment Status: | Not debarred by any SEBI Order or other authority | N.A. |
Profile of Dr. Vinita Jha — Independent Director
Dr. Vinita Jha brings a decade of senior leadership experience in corporate hospitals, with a background spanning clinical operations, P&L management, and clinical policy formulation. Her professional qualifications include:
- CCT Psych UK (2004)
- MBA, Cardiff, UK (2000–2002) — Human Resource & Marketing
- MBBS, Bihar (1996)
- ISC, De Nobili School, Dhanbad (1989)
- ICSE, De Nobili School, Dhanbad (1987)
Her professional career includes roles such as Senior Vice President – Clinical Directorate (July 2014 onwards), Director – Ops at Max Health Care (June 2012 to June 2014), General Manager – Ops at Max Hospital, Gurgaon (July 2010 to June 2012), Department Head at Max Home Care, New Delhi (May 2009 to June 2010), Independent Health Consultant for major corporates in India (2008–2009), Advisory Consultant at Max Health Care, New Delhi (2007), Senior House Officer at Somerset Partnership NHS Trust, UK (2004 to 2007), Business Manager at Shamrock House, Goole, UK (2003 to 2004), and Research Lead for Gates Foundation & WHO, Bihar (1997 to 2000).
Profile of M/s Lodha & Co. — Statutory Auditors
M/s Lodha & Co., Chartered Accountants, have been present in India for over seven decades, having been established in 1941. The firm operates six offices across India and is also a member firm of an International Network, with a dedicated staff strength of approximately 300 personnel.
The firm's standing in the industry is supported by the following credentials:
- Ranked 7th overall in India's top firms by a 2006 research report by M/s Prime Knowledge Series — the only accounting firm in the Top 10 list not part of the 'Big Four'
- Ranked 3rd in terms of "Points Scored" on an index of geographical spread
- Ranked 4th in terms of the number of audits
- Ranked 10th in terms of the revenue of clients
- Registered with PCAOB, enabling the firm to conduct audits of significant Indian subsidiaries/associates of companies listed in the USA
- Completed a satisfactory PCAOB review for a US-based company, a significant subsidiary of which is audited by the firm
- Domestic external Peer Reviews conducted by the Institute of Chartered Accountants of India in 2005, 2009, 2014, 2018, and 2021 all resulted in positive reports
Regulatory Compliance
The disclosures were made in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with SEBI Circular no. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026. The filing was signed by Pravesh Srivastava, CEO & Company Secretary of Hexa Tradex Limited.
Historical Stock Returns for Hexa Tradex
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.29% | -2.49% | +0.77% | -5.48% | -12.32% | +38.24% |
How might Dr. Vinita Jha's healthcare and clinical operations background influence Hexa Tradex's strategic direction or potential diversification into health-related sectors?
Given that M/s Lodha & Co.'s industry rankings are based on a 2006 report, how does the firm's current standing compare to emerging audit firms and evolving Big Four dominance in India?
What are the potential risks to shareholder approval of these re-appointments at the AGM, and how could dissenting votes impact Hexa Tradex's governance continuity?
































